Experimental vaccination might prevent the aggressive brain tumor’s recurrence
In a trial involving 63 patients, the vaccine, known as SurVaxM, was found to almost double the survival time. In …
In a trial involving 63 patients, the vaccine, known as SurVaxM, was found to almost double the survival time. In …